Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: Results of a randomized clinical trial

Journal of Clinical Psychopharmacology

Volumn 25, Issue 5, 2005, Pages 490-493

  Soyka, Michael ^a   Hock, Bettina ^a   Kagerer, Sabine ^a   Lehnert, Robert ^a   Limmer, Claudia ^a   Kuefner, Heinrich ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b IFT INSTITUT FÜR THERAPIEFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; MU OPIATE RECEPTOR AGONIST;

ADULT; AGE; ALERTNESS; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRIVING ABILITY; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SELECTIVE ATTENTION; SOCIAL STATUS; STRESS; VISION;

ADULT; AGING; ATTENTION; AUTOMOBILE DRIVING; BUPRENORPHINE; COGNITION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; METHADONE; MIDDLE AGED; NARCOTIC ANTAGONISTS; NEUROPSYCHOLOGICAL TESTS; OPIOID-RELATED DISORDERS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; VERBAL BEHAVIOR; VISUAL PERCEPTION;

EID: 25444447770     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000178417.60426.60     Document Type: Article

References (31)

1. Amass L, Kamien JB, Mikulich SK. Efficacy of daily and alternate-day dosing regimens with the combination of buprenorphine-naloxone tablet. Drug Alcohol Depend. 2000;58:143-152.
2. Bickel WK, Amass L, Crean JP, et al. Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients. Psychopharmacology. 1999;146:111-118.
3. Barnett PG, Rodgers JH, Bloch DA. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction. 2001;96:683-690.
4. Ling W, Charavustra C, Collins JF, et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter randomized clinical trial. Addiction. l998;93:475-486.
5. Ling W, Wesson DR, Charuvasta C, et al. A Controlled trial comparing buprenorphine and methadone maintenance opioid dependence. Arch Gen Psychiatry. 1996;53:401-407.
6. Kakko J, Svanborg KD, Kreek MJ, et al. 1-Year retention and social function after buprenorphine-assisted relapse prevention for heroin dependence in Sweden: a randomized, placebo-controlled trial. Lancet. 2003;361:662-668.
7. Davids E, Gastpar M. Buprenorphine in the treatment of opioid dependence. Eur Neuropsychopharmacol. 2004;14:209-216.
8. Pirnay S, Borron SW, Giudicelli CP, et al. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction. 2004;99:978-988.
9. Dittert S, Naber D, Soyka M. Methadone substitution and ability to drive. Results of an experimental study [in German]. Nervenarzt. 1999;70:457-462.
10. Specka M, Finkbeiner Th, Lodemann E, et al. Cognitive-motor performance of methadone-maintained patients. Eur Addict Res. 2000;6:8-19.
11. Lenné MG, Rumbold G, Redman JR, et al. Opioid dependence and driving ability: a review in the context of proposed legislative change in Victoria. Drug Alcohol Rev. 2000;4:427-439.
12. Zacny JP. Should people taking opioids for medical reasons be allowed to work and drive? Addiction. 1995;91:1581-1584.
13. Mintzer MZ, Stitzner ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002;67:41-51.
14. Strain EC, Preston KL, Liebson IA, et al. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone. J Pharmacol Exp Ther. 1995;261:985-993.
15. Soyka M, Horak M, Dittert S, et al. Less driving impairment on buprenorphine than methadone in drug-dependent patients? J Neuropsychiatry Clin Neurosci. 2001;13:527-528.
16. Buehringer G, Kroeger C, Kuefner H, et al. Substance abuse research network ASAT: allocating substance abuse treatments to patient heterogeneity [in German]. Suchtmed. 2004;6:7-13.
17. Kuefner H, Hackmann K, Schnabel A, et al. Optimizing substitution treatment in drug dependence (OSTD): withdrawal symptoms and craving during the first week [in German]. Suchtmed. 2004;6:95-97.
18. Brickenkamp R. Aufmerksamkeitsbelastungstest d2. Hogrefe Verlag: Göttingen; 2002.
19. Tewes U. Hamburg-Wechsler-Intelligenztest für Erwachsene-Revision 1991, deutsche Fassung. Hogrefe Verlag: Göttingen; 1991.
20. Aschenbrenner S, Tucha O, Lange KW. Regensburger Wortflüssigkeits- Test. Hogrefe Verlag: Göttingen; 2000.
21. Caine ED, Boghos MD, Yrevanian BI, et al. Cognitive function and the dexamethasone suppression test in depression. Am J Psychiatry. 1984;141:115-118.
22. Martin RC, Loring DW, Meador KJ, et al. The effects of lateralized temporal lobe dysfunction on formal and semantic word fluency. Neuropsychologia. 1990;28:823-829.
23. Hart RP, Kwentus JA, Taylor JR, et al. Productive naming and memory in depression and Alzheimer's type dementia. Arch Clin Neuropsychol. l988;3:313-322.
24. Kisser R, Wenninger U. Computerunterstuetztes Testen im Rahmen der Fahreignungsuntersuchung (Act & React Test System ART-90). Kleine Fachbuchreihe des Kuratoriums für Verkehrssicherheit, 20. Wien: Kuratorium für Verkehrssicherheit; 1983.
25. Lewrenz H. Begutachtungs-Leitlinien zur Kraftfahrereignung des Gemeinsamen Beirats für Verkehrsmedizin beim Bundesministerium für Verkehr, Bau und Wohnungswesen beim Bundesministerium für Gesundheit, Berichte der Bundesanstalt für Straßenwesen. Heft M115. Bergisch Gladbach; 2000.
26. Brunnauer A, Laux G, Geiger E, et al. The impact of antipsychotics on psychomotor performance with regards to car driving skills. J Clin Psychopharmacol. 2004;24:155-160.
27. Soyka M, Winter C, Kagerer S, et al. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls. J Psychiatr Res. 2005;39:101-108.
28. Bukasa B, Christ R, Pocorny-Seliger E, et al. Validitätsü berprüfung verkehrspsychologischer Leistungstests für die Fahreignungsbegutachtung. Zeitschrift für Verkehrssicherheit. 2003;49(nr 4):191-197.
29. Bukasa B, Kisser R, Wenninger U. Computergestützte Leistungsdiagnostik bei verkehrspsychologischen Eignungsuntersuchungen. Diagnostika. 1990;36:148-165.
30. Lenné MG, Dietze P, Rumbold GR, et al. The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on stimulated driving. Drug Alcohol Depend. 2003;72:271-278.
31. Shindler S-D, Ortner R, Peternell A, et al. Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res. 2004;10:80-97.